| Volume 12, 2008 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Year Number 12…And Still Much Work to Do
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 4
|
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G, Abdulmohsin Saud
|
Jan/Feb 2008
Pg. 8-14
|
Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients
Williams LaVonn A
|
Jan/Feb 2008
Pg. 16-27
|
Hospice and Compounding Pharmacy: Once Inseperable
Williams LaVonn A
|
Jan/Feb 2008
Pg. 28-37
|
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
|
Jan/Feb 2008
Pg. 38-47
View Sample |
Websites: Keeping Current in 2008
Storey Patricia L
|
Jan/Feb 2008
Pg. 48-49
|
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method
Kupiec Thomas C, Skinner Rodney, Lanier Lance
|
Jan/Feb 2008
Pg. 50-53
|
Calculations: Compounding for Cancer Patients
Stockton Shelly J
|
Jan/Feb 2008
Pg. 62
|
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 63
|
Cyclosporine Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 64
|
Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 65
|
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 66
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008
Pg. 54-60
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 67
|
Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 68
|
Flosulide 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 69
|
Pentoxifylline 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 70
|
Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 71
|
Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 72
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 73
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008
Pg. 83-85
|
2007 Reviewers
|
Jan/Feb 2008
Pg. 86
|
PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
|
Jan/Feb 2008
Pg. 87
|
PreScription: Compounding Around the World
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 92
|
Current Compounding Practices in Europe
Carvalho Maria, Tuleu Catherine, Taylor Kevin MG
|
Mar/Apr 2008
Pg. 94-99
|
Compounding Around the World
Vail Jane
|
Mar/Apr 2008
Pg. 102-115
|
Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
|
Mar/Apr 2008
Pg. 116-120
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
Newsletters: An Essential Marketing Tool
Storey Patricia L
|
Mar/Apr 2008
Pg. 128-129
|
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
|
Mar/Apr 2008
Pg. 130-135
|
Calculations
Stockton Shelly J
|
Mar/Apr 2008
Pg. 145
|
Acyclovir 5% Topical Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 146
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Chemical Stability of Tramadol Hydrochloride Injection
Gupta Vishnu D
|
Mar/Apr 2008
Pg. 161-162
|
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson, Holandino Carla
|
Mar/Apr 2008
Pg. 163-169
|
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
|
Mar/Apr 2008
Pg. 174-175
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008
Pg. 136-144
|
Alum 6.5% Topical Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 147
|
Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 148
|
Butesin Picrate 1% ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 149
|
Carbamazepine Topical Preparations
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 150
|
Chlorhexidine Gel
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 151
|
EDTA 1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 152
|
Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 153
|
Heparin Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 154
|
Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 155
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2008
Pg. 252-257
|
Calculations
Stockton Shelly J
|
May/Jun 2008
Pg. 258
|
Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription
Allen Loyd V Jr
|
May/Jun 2008
Pg. 259
|
African Scalp Lotion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 260
|
Benzyl Benzoate Lotion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 261
|
Calcium Gluconate 2.5% Topical Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 262
|
Lubricating Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 263
|
Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 264
|
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
|
May/Jun 2008
Pg. 265
|
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 266
|
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2008
Pg. 267
|
Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 268
|
Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2008
Pg. 269
|
Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
|
May/Jun 2008
Pg. 274-275
|
PostScription: A Contemporary Perspective on Compounding Education
Maine Lucinda L
|
May/Jun 2008
Pg. 279
|
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
|
May/Jun 2008
Pg. 216-229
|
Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations
Fyke Jeremy P, Hoffman Mary F
|
May/Jun 2008
Pg. 230-233
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement
Cabaleiro Joe
|
May/Jun 2008
Pg. 234-236
|
PreScription: Pain!
Allen Loyd V Jr
|
May/Jun 2008
Pg. 180
|
Topical Treatment of Neuropathic Pain
Vadaurri Vince
|
May/Jun 2008
Pg. 182-190
|
Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
|
May/Jun 2008
Pg. 192-197
|
Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony, Fakata Keri, Stuart William
|
May/Jun 2008
Pg. 200-207
|
Pharmacy Compounding at the University of Connecticut: Secundum Artem et Scientia
Scagliarini Meghan, Bogner Robin H
|
May/Jun 2008
Pg. 208-212
|
Developing and Implementing a Clinical Pharmacy Rotation in a Community Compounding Pharmacy
Walkup Kenny R
|
May/Jun 2008
Pg. 213-215
|
Litigating the Legality of Compounding: The Medical Center Pharmacy Case
Gibbs Jeffrey N
|
May/Jun 2008
Pg. 238-241
|
Developing a Niche Marketing Strategy
Storey Patricia L
|
May/Jun 2008
Pg. 242-243
|
Web 2.0 and Health 2.0: Are You In?
Felkey Bill G
|
May/Jun 2008
Pg. 244-246
|
A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
|
May/Jun 2008
Pg. 247-251
|
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S, Banov Daniel, Lehman Paul A
|
May/Jun 2008
Pg. 270-273
|
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008
Pg. 276-278
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Zirconium Oxide Lotion
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 364
|
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008
Pg. 365-367
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
The Magic of Magnesium
Boomsma Diane
|
Jul/Aug 2008
Pg. 306-309
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
|
Jul/Aug 2008
Pg. 316-320
|
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
|
Jul/Aug 2008
Pg. 321-327
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C, Felkey Bill G
|
Jul/Aug 2008
Pg. 334-337
|
Marketing for Your Community
Storey Patricia L
|
Jul/Aug 2008
Pg. 338-339
|
Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C, Vu Nicole, Branscum David
|
Jul/Aug 2008
Pg. 340-343
|
Calculations
Stockton Shelly J
|
Jul/Aug 2008
Pg. 354
|
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 355
|
Silicone Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 356
|
Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 357
|
Squalene 0.2% Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 358
|
Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 359
|
Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 360
|
Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 361
|
Ultrasonic Adhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 362
|
Vitamin A Suppository
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 363
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
PreScription: Compounding Around the World
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 382
|
Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
|
Sep/Oct 2008
Pg. 384-390
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
|
Sep/Oct 2008
Pg. 398-401
|
Equine Anesthesia: Triple Drip
Davidson Gigi S
|
Sep/Oct 2008
Pg. 402-404
|
Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information
Neal Amy S, DeVeau Ian, Schnatz Rick G
|
Sep/Oct 2008
Pg. 405-409
|
Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship
Kirk Loren Madden
|
Sep/Oct 2008
Pg. 410-413
|
Calculations
Stockton Shelly J
|
Sep/Oct 2008
Pg. 444-445
|
Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 446
|
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
|
Sep/Oct 2008
Pg. 456-459
|
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008
Pg. 460-462
|
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Sep/Oct 2008
Pg. 463-466
|
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008
Pg. 414-418
|
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?
Baker Kenneth R
|
Sep/Oct 2008
Pg. 420-424
|
Excipient Choices for Special Populations
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008
Pg. 426-430
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations
Cabaleiro Joe
|
Sep/Oct 2008
Pg. 432-433
|
Technology for the Patient-Centric Pharmacy
Felkey Bill G
|
Sep/Oct 2008
Pg. 434-437
|
Acetaminophen 10-mg/mL Rectal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 447
|
Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 448
|
Marketing: Taking Your Show on the Road
Storey Patricia L
|
Sep/Oct 2008
Pg. 438-439
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2008
Pg. 440-443
|
Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 449
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
Flurandrenolide Topical Film
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 451
|
Ketoprofen 20% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 452
|
Lidocaine Adhesive System Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 453
|
Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 454
|
Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 455
|
PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership
Marro Diego, Barbosa Carlos Mauricio
|
Sep/Oct 2008
Pg. 467
|
Prescription: Is "Globalization" a Good Idea?
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 474
|
Arthritis Epidemiology Impacts Pharmacists
Vance Dwight A
|
Nov/Dec 2008
Pg. 476-480
|
Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
|
Nov/Dec 2008
Pg. 482-487
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Symbols: Historic and Current Uses
Bailey Emilee
|
Nov/Dec 2008
Pg. 505-507
|
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Nov/Dec 2008
Pg. 508-513
|
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
|
Nov/Dec 2008
Pg. 524-528
|
Calculations
Stockton Shelly J
|
Nov/Dec 2008
Pg. 539
|
Glycerin, Sterile
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 542
|
Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 543
|
Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 544
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Nov/Dec 2008
Pg. 488-497
|
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where
Baker Kenneth R
|
Nov/Dec 2008
Pg. 514-523
|
Branding: Give Your Small Business a Big Image
Storey Patricia L
|
Nov/Dec 2008
Pg. 537-538
|
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 540
|
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 541
|
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 545
|
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 547
|
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 548
|
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 549
|
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Donnelly Ronald F, Corman Celine
|
Nov/Dec 2008
Pg. 550-552
|
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Nov/Dec 2008
Pg. 553-557
|
PostScription: Supporting Compounding Around the World
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 565
|
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 530-536
|
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
